title: Safety and immunogenicity of Salmonella typhi Ty21a liquid formulation vaccine in 4- to 6-year-old Thai children.
authors.forename: T
authors.initials: T
authors.lastname: Olanratmanee
authors.forename: M
authors.initials: M
authors.lastname: Levine
authors.forename: G
authors.initials: G
authors.lastname: Losonsky
authors.forename: V
authors.initials: V
authors.lastname: Thisyakorn
authors.forename: S J
authors.initials: SJ
authors.lastname: Cryz
mesh_terms: D000367:Age Factors; D000907:Antibodies, Bacterial / Q000097:blood*; D002648:Child; D002675:Child, Preschool; D004311:Double-Blind Method; D006801:Humans; D012485:Salmonella typhi / Q000276:immunology*; D014436:Typhoid-Paratyphoid Vaccines / Q000009:adverse effects* / Q000276:immunology; D014613:Vaccines, Attenuated / Q000009:adverse effects / Q000276:immunology
chemical_list: D000907:Antibodies, Bacterial; D014436:Typhoid-Paratyphoid Vaccines; D014613:Vaccines, Attenuated